Brachial Plexus Injury
Conditions
Interventions
Gold Standard:the MRI exam finding of brachial plexus
Sponsors
Jing'an District Central Hospital of Shanghai
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients to be diagnosed with suspected severe brachial plexus nerve injury resulting in limb dysfunction. 2. Patients with suspected brachial plexus injury proposed to be diagnosed with nerve root avulsion or rupture. 3. Patients with suspected brachial plexus injury who have a clear history of upper limb brachial plexus or peripheral nerve injury that failed to heal spontaneously and require surgical treatment. 4. Patients with obvious muscle atrophy suspected of brachial plexus nerve injury who need surgical exploration and treatment. 5. Patients with suspected brachial plexus nerve injury who have a history of brachial plexus nerve injury with long-term pain affecting quality of life, ineffective conservative treatment, and are scheduled for brachial plexus neurolysis to relieve pain. 6. Patients with mild brachial plexus injury who have not fully recovered after rehabilitation and require further brachial plexus neurolysis. Patients who meet one of the above criteria, have no disturbance of consciousness, voluntarily sign the informed consent form and participate in this study, with no age restriction.
Exclusion criteria
Exclusion criteria: 1. Patients with concurrent neuritis; 2. Patients who have not undergone brachial plexus nerve surgery; 3. Patients with disturbance of consciousness; 4. Patients who are unwilling to sign the informed consent form and participate in this study; 5. Patients with a history of allergy to contrast agents; 6. Pregnant or lactating women; 7. Patients with concurrent severe cardiopulmonary dysfunction; 8. Pediatric patients under 18 years old. Contrast-enhanced ultrasound is prohibited for the above groups to ensure the safety of subjects and reduce potential adverse reactions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency evaluation;sensitivity;specificity;accuracy;positive predictive value;negative predictive value; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of adverse events and serious adverse events; | — |
Countries
China
Contacts
Public ContactDing Yueyue
Jing'an District Central Hospital of Shanghai
Outcome results
None listed